ENGN · enGene Therapeutics Inc.
$1.95
+0.08 (+4.28%)
At close · Aug 26
Market Cap
$125.27M
Shares
66.99M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ENGN
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund | — | 486,579 | $3,537,429 | 0.34% | Long | 2026-04-30 | |
| Virtus Biotech Clinical Trials Etf | — | 32,625 | $237,184 | 0.64% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 40,733 | $75,356 | 0.00% | Long | 2026-05-31 | |
| JNL/DFA U.S. Small Cap Fund | — | 9,974 | $17,255 | 0.00% | Long | 2026-06-30 | |
| NORTH SQUARE KENNEDY MICROCAP FUND | — | 7,649 | $14,151 | 0.04% | Long | 2026-05-31 | |
| AST Small-Cap Equity Portfolio | — | 1,376 | $2,380 | 0.00% | Long | 2026-06-30 |
Showing 1–6 of 6 positions